This is a working overview of reference standard, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-04-05. Anything still debated is marked as such rather than presented as settled.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule nuclear receptor ligand |
| Appearance | Off-white to pale yellow solid | Typical for research-grade powder |
| Solubility class | Soluble in DMSO; low water solubility | Common stock solutions use organic solvent |
| Typical stock solvent | Dimethyl sulfoxide | Used for laboratory assays |
| Common analytical method | HPLC with UV or mass detection | Used for identity and purity checks |
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
PA 6 or Nylon 6: [NH−(CH2)5−CO]n made from ε-caprolactam. Two numbers or sets of letters indicate a dyadic homopolymer formed from two monomers: one diamine and one dicarboxylic acid. The first number indicates the number of carbons in the diamine. The two numbers should be separated by a comma for clarity, but the comma is often omitted.
With each successive cycle, the original template strands plus all newly generated strands become template strands for the next round of elongation, leading to exponential (geometric) amplification of the specific DNA target region. The processes of denaturation, annealing and elongation constitute a single cycle. Multiple cycles are required to amplify the DNA target to millions of copies. The formula used to calculate the number of DNA copies formed after a given number of cycles is 2n, where n is the number of cycles. Thus, a reaction set for 30 cycles results in 230, or 1,073,741,824 copies of the original double-stranded DNA target region. Final elongation: This single step is optional, but is performed at a temperature of 70–74 °C (158–165 °F) (the temperature range required for optimal activity of most polymerases used in PCR) for 5–15 minutes after the last PCR cycle to ensure that any remaining single-stranded DNA is fully elongated. Final hold: The final step cools the reaction chamber to 4–15 °C (39–59 °F) for an indefinite time, and may be employed for short-term storage of the PCR products.
Other stressors that can stimulate increased solanine biosynthesis include mechanical damage, improper storage conditions, improper food processing, and sprouting. The largest concentration of solanine in response to stress is on the surface in the peel, making it an even better defense mechanism against pests trying to consume it.
Colleagues recounted him saying that he didn't like working on minor injury wards or with old people and wanted to work in the emergency department because it was more 'exciting' for him. He said he "wasn't put on this earth to sit in an office." The hospital later found out that he had been secretly working as a nurse in other hospitals on occasions when he claimed to be off sick or attending a training course. His former partner said after his conviction that Norris had once hit him during an argument, bruising his head and once threw a bottle at him, which caused him to break up with Norris. He also said that, around the time of the murders, Norris had become engrossed by a storyline in Holby City, in which a serial killer nurse played by Rachel Leskovac killed patients with insulin before eventually being uncovered as a murderer. This same storyline is believed to have inspired another UK nurse, Benjamin Geen, to kill his patients. In the month in which he began killing patients with overdoses, Geen appeared in an edition of the Banbury Citizen which featured an interview with Leskovac. Norris's partner also revealed, after Norris's conviction, that Norris had experimented on his cat Casper before he began killing patients, injecting it with a lethal dose of insulin. The partner had reported him to the police but Norris claimed the cat had died from hitting its head on a wall.
Sources: en.wikipedia.org
=== US rationale === The Trump administration did not initially announce any specific legal authority for the first strike. Secretary of Defense Pete Hegseth declared, "We have the absolute and complete authority", citing "... the defense of the American people alone. 100,000 Americans were killed each year under the previous administration because of an open border and open drug traffic flow. That is an assault on the American people." Regarding the initial strike, the Trump administration did not provide evidence about the vessel's cargo, nor did it establish that the vessel's crew were threatening to attack. Trump was questioned on 5 September about the legality of the first strike, to which he responded: "We don't want drugs killing our people. I believe we lost 300,000 ... last year"—a number he repeated days later in an Oval Office meeting. Drug overdose deaths in the US in 2024 were about 80,000 according to the US Centers for Disease Control and Prevention, representing a 25 percent decline from the previous year deaths of 112,910. When speaking impromptu to reporters prior to boarding Air Force One on 14 September, Trump inflated that number to 300 million. CNN states that "allegations involving [Venezuela's] presidential palace in cocaine trafficking have existed for at least a decade." Former US Attorney General William Barr first accused Maduro of supporting drug trafficking in 2020, stating that 250 tons of cocaine are smuggled through Venezuela annually, facilitated by the government, although no evidence was presented.
Upon impact with the samples x-rays are emitted that can be used to identify the composition of the shell. X-ray diffraction is a method for determining eggshell composition that uses X-rays to directly bombard powdered eggshell. Upon impact some of the x-rays will be diffracted at different angles and intensities depending on the specific elements present in the eggshell. Allosterics In order to test out how allosterics played a part in dinosaur egg size, scientists used modern day animal species such as birds, crocodiles, and tortoises in their experiment. They set the bird group as representing the theropods with the reptiles representing the sauropod group. The laid eggs of each species where compared with one another over the course of the study as well as against the fossilized eggs. The results that was retrieved from the experiment was that while sauropods laid smaller eggs in greater amounts each year, dinosaur of the theropod group was revealed to lay larger eggs less frequently over the years, similar to modern birds today.
The Sino-Soviet split was one of the key events of the Cold War, equal in importance to the construction of the Berlin Wall, the Cuban Missile Crisis, the Second Vietnam War, and Sino-American rapprochement. The split helped to determine the framework for the Cold War period 1979–1985 in general, and influenced the course of the Second Vietnam War in particular.
October 24, 2008: Iceland Iceland receives a £1.3 billion (US$2.06 billion, €1.63 billion) bailout package from the International Monetary Fund as the first European country to require an emergency loan with the aim of stabilising the collapsed currency and strengthening the tax system as well as the nationalised banks.
== Mycelium-based textiles == Mycelium, the vegetative part of fungi, has emerged as a versatile and sustainable raw material for biotextiles. Mycelium typically grows underground or within its substrate such as soil, wood, decaying organic matter or waste residues. In mycelium-based biocomposites, the fungus consumes the carbohydrates to produce hyphae, a network of branching, thread-like structures. Through controlled growth processes, mycelium can be cultivated into a dense network of interwoven fibers, forming a durable biodegradable matrix suitable for textile applications. This cultivation depends on the temperature, moisture and pH of the media.
Sources: en.wikipedia.org
=== Music === Cold Case Files (2008) and Cold Case Files Vol. 2 (2012) are compilation albums by the rap group Onyx. "Cold Case Love" is a song on Rihanna's Rated R album, released November 23, 2009 on the Def Jam label. "Stella: The Cold Case" is an EP by Aafke Romeijn.
=== Model cancers === For cancer studies, it is desirable that the oncolytic virus be non-pathogenic for experimental animals, but the Sendai virus can cause rodent disease, which is a problem for research strategies. Two approaches have been used to overcome this problem and make Sendai virus non-pathogenic for mice and rats. One of these approaches included the creation of a set of genetically modified attenuated viral strains. Representatives of this set were tested on model animals carrying a wide range of transplantable human tumors. It has been shown that they can cause suppression or even eradication of fibrosarcoma, neuroblastoma, hepatocellular carcinoma, melanoma, squamous cell and prostate carcinomas. SeV construct suppresses micrometastasis of head and neck squamous cell carcinoma in an orthotopic nude mouse model. Complete eradication of established gliosarcomas in immunocompetent rats has also been observed. SeV constructs have also been created with a modified protease cleavage site in the F-protein. The modification allowed the recombinant virus to specifically infect cancer cells that expressed the corresponding proteases.
Clinical pathology is a medical specialty that is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids such as blood and urine, as well as tissues, using the tools of chemistry, clinical microbiology, hematology and molecular pathology. Clinical pathologists work in close collaboration with medical technologists, hospital administrations, and referring physicians. Clinical pathologists learn to administer a number of visual and microscopic tests and an especially large variety of tests of the biophysical properties of tissue samples involving automated analysers and cultures. Sometimes the general term "laboratory medicine specialist" is used to refer to those working in clinical pathology, including medical doctors, Ph.D.s and doctors of pharmacology. Immunopathology, the study of an organism's immune response to infection, is sometimes considered to fall within the domain of clinical pathology.
Atmospheric-pressure chemical ionization uses a solvent spray at atmospheric pressure. A spray of solvent is heated to relatively high temperatures (above 400 degrees Celsius), sprayed with high flow rates of nitrogen and the entire aerosol cloud is subjected to a corona discharge that creates ions with the evaporated solvent acting as the chemical ionization reagent gas. APCI is not as "soft" (low fragmentation) an ionization technique as ESI. Note that atmospheric pressure ionization (API) should not be used as a synonym for APCI.
As of 2023, Thermos and THERMOS remain a registered trademark in some countries, including the United States, but the lowercase "thermos" was declared a genericized trademark by court action in the United States in 1963.
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.
It binds REV-ERB alpha and REV-ERB beta and changes the expression of genes tied to metabolism and circadian rhythm. These changes can affect mitochondria and energy use in animal models. The exact chain from receptor binding to physiological outcome is still being mapped.
No reliable human trials show that SR9009 improves athletic performance. Some rodent studies report endurance changes, but these results are not proof of human benefit. Its use in sport is prohibited, and quality and safety data are lacking.
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.